Literature DB >> 16968175

Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells.

Gilad E Amiel1, Makoto Komura, Oz Shapira, James J Yoo, Saami Yazdani, Joel Berry, Sunjay Kaushal, Joyce Bischoff, Anthony Atala, Shay Soker.   

Abstract

Small-caliber synthetic grafts used for coronary bypass artery grafting are compromised by thrombogenicity and accelerated intimal thickening, resulting in early graft occlusion. Herein we describe the fabrication and physical properties of small-caliber blood vessels using decellularized porcine aortic segments. These vessels were further coated with human saphenous vein endothelial cells (HSVECs) for future clinical applications. Chemical staining of decellularized vessels showed that they preserved their native matrix architecture, including several collagen layers in between internal and external elastin layers. The burst pressure for the decellularized vessels was higher than 1,000 mmHg. HSVECs, seeded on the luminal side, adhered to the matrix and formed a uniform monolayer. HSVEC-seeded vessels produced prostaglandin I2 and released vasoactive agents in response to the calcium ionophore A23187. These results show that engineered blood vessels coated with the host endothelial cells possess morphologic and functional characteristics of human small-caliber vessels. Tissue-engineered vessels may potentially be useful clinically as vascular grafts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968175     DOI: 10.1089/ten.2006.12.2355

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  31 in total

1.  Elastomeric polypeptide-based biomaterials.

Authors:  Linqing Li; Manoj B Charati; Kristi L Kiick
Journal:  J Polym Sci A Polym Chem       Date:  2010-10       Impact factor: 2.702

Review 2.  Review: advances in vascular tissue engineering using protein-based biomaterials.

Authors:  Jan P Stegemann; Stephanie N Kaszuba; Shaneen L Rowe
Journal:  Tissue Eng       Date:  2007-11

3.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

Review 4.  Endothelial outgrowth cells: function and performance in vascular grafts.

Authors:  Jeremy J Glynn; Monica T Hinds
Journal:  Tissue Eng Part B Rev       Date:  2013-10-10       Impact factor: 6.389

5.  Rapid biofabrication of tubular tissue constructs by centrifugal casting in a decellularized natural scaffold with laser-machined micropores.

Authors:  Vladimir A Kasyanov; Jason Hodde; Michael C Hiles; Carol Eisenberg; Leonard Eisenberg; Luis E F De Castro; Iveta Ozolanta; Modra Murovska; Robert A Draughn; Glenn D Prestwich; Roger R Markwald; Vladimir Mironov
Journal:  J Mater Sci Mater Med       Date:  2008-09-20       Impact factor: 3.896

6.  Decellularized tissue-engineered blood vessel as an arterial conduit.

Authors:  Clay Quint; Yuka Kondo; Roberto J Manson; Jeffrey H Lawson; Alan Dardik; Laura E Niklason
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-12       Impact factor: 11.205

7.  A novel technique for simultaneous whole-body and multi-organ decellularization: umbilical artery catheterization as a perfusion-based method in a sheep foetus model.

Authors:  Abdol-Mohammad Kajbafzadeh; Reza Khorramirouz; Aram Akbarzadeh; Shabnam Sabetkish; Nastaran Sabetkish; Paria Saadat; Mona Tehrani
Journal:  Int J Exp Pathol       Date:  2015-04       Impact factor: 1.925

8.  Optimum parameters for freeze-drying decellularized arterial scaffolds.

Authors:  William S Sheridan; Garry P Duffy; Bruce P Murphy
Journal:  Tissue Eng Part C Methods       Date:  2013-06-25       Impact factor: 3.056

9.  Mechanical evaluation of decellularized porcine thoracic aorta.

Authors:  Yu Zou; Yanhang Zhang
Journal:  J Surg Res       Date:  2011-04-21       Impact factor: 2.192

Review 10.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.